[June 09, 2016]

Juvenile Idiopathic Arthritis Forecast in 8 Major Markets 2016-2026 - Risk Factors & Prevention - Research and Markets

Research and Markets has announced the addition of the "Juvenile Idiopathic Arthritis Forecast in 8 Major Markets 2016-2026" report to their offering.

Juvenile Idiopathic Arthritis (JIA) is an auto-immune disorder defined as inflammation of the joints. For diagnosis, the inflammation in one or more of the joints must be present for at least six weeks, affecting children under the age of 16. There are 6 main types of JIA:

1. Systemic
2. Oligoarticular
3. Polyarticular
4. Psoriatic
5. Enthesitis-related
   
6. Undifferentiated.

Patients with JIA have a prolonged inflammatory response, and the reasons for these excessive inflammatory responses are still unknown. This report provides the current prevalent population for JIA across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year agecohort.

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Main symptoms and co-morbidities for JIA include:

• Uveitis and associated complications
• Iridiocyclitis
• Joint and muscle pain
• Osteoporosis
• Osteopenia
• Macrophage Activation Syndrome
  

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis (News - Alert) & Clinical Course

7. Key Co-morbid Conditions /Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Juvenile Idiopathic Arthritis

10. Features of Juvenile Idiopathic Arthritis Patients

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

For more information visit http://www.researchandmarkets.com/research/hw5qjh/juvenile

View source version on businesswire.com: http://www.businesswire.com/news/home/20160609005523/en/

[ Back To TMCnet.com's Homepage ]